AFEYAN NOUBAR

AFEYAN NOUBAR, Director, has filed 6 insider trading reports covering 2 companies. Total disclosed trading volume is $152.8M. The predominance of buying activity ($150.0M in purchases vs. $703.3K in sales) may reflect this insider's confidence in the underlying companies. The largest single filing involves Generate Biomedicines, Inc. (GENB). All transactions sourced from SEC Form 4 filings.